Cite
HARVARD Citation
Yu, Y. et al. (n.d.). High‐dose dexamethasone plus recombinant human thrombopoietin vs high‐dose dexamethasone alone as frontline treatment for newly diagnosed adult primary immune thrombocytopenia: A prospective, multicenter, randomized trial. American journal of hematology. 95 (12), pp. 1542-1552. [Online].